Study on the pain of cancer caused by the combination of electric needle ear acupuncture and drugs on renal deficiency blood stasis bone metastasis

注册号:

Registration number:

ITMCTR2100005442

最近更新日期:

Date of Last Refreshed on:

2021-12-24

注册时间:

Date of Registration:

2021-12-24

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

电针耳穴联合药物对肾虚血瘀骨转移癌痛研究

Public title:

Study on the pain of cancer caused by the combination of electric needle ear acupuncture and drugs on renal deficiency blood stasis bone metastasis

注册题目简写:

English Acronym:

研究课题的正式科学名称:

电针耳穴联合药物对骨转移癌痛研究

Scientific title:

Electro-acupuncture ear acupuncture combined with drugs for bone metastatic cancer pain study

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2100054708 ; ChiMCTR2100005442

申请注册联系人:

张娜

研究负责人:

张娜

Applicant:

Na Zhang

Study leader:

Na Zhang

申请注册联系人电话:

Applicant telephone:

13544526239

研究负责人电话:

Study leader's telephone:

18665693099

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1043728951@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1043728951@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

广州市黄埔区黄埔街丰乐南路88号大院23#首层

研究负责人通讯地址:

广州市黄埔区黄埔街丰乐南路88号大院23#首层

Applicant address:

Guangzhou University of Traditional Chinese Medicine, No. 12 Airport Road, Baiyun District, Guangzhou

Study leader's address:

The first floor of the 23# compound at No. 88 Fengle South Road, Huangpu Street, Huangpu District, Guangzhou

申请注册联系人邮政编码:

Applicant postcode:

510700

研究负责人邮政编码:

Study leader's postcode:

510700

申请人所在单位:

广州市黄埔区黄埔街社区卫生服务中心

Applicant's institution:

Huangpu Street Community Health Service Center, Huangpu District, Guangzhou

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2020001

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

广州市黄埔区黄埔街社区卫生服务中心伦理委员会

Name of the ethic committee:

Ethics Committee of Huangpu Street Community Health Service Center, Huangpu District, Guangzhou

伦理委员会批准日期:

Date of approved by ethic committee:

1990/1/1 0:00:00

伦理委员会联系人:

李皓

Contact Name of the ethic committee:

Li Hao

伦理委员会联系地址:

广州市黄埔区丰乐南路88号大院23#首层

Contact Address of the ethic committee:

Guangzhou University of Traditional Chinese Medicine, No. 12 Airport Road, Baiyun District, Guangzhou

伦理委员会联系人电话:

Contact phone of the ethic committee:

13533575282

伦理委员会联系人邮箱:

Contact email of the ethic committee:

2361186918@qq.com

研究实施负责(组长)单位:

广州市黄埔区黄埔街社区卫生服务中心

Primary sponsor:

Huangpu Street Community Health Service Center, Huangpu District, Guangzhou

研究实施负责(组长)单位地址:

广州市黄埔区丰乐南路88号大院23#首层

Primary sponsor's address:

The first floor of the 23# compound at No. 88 Fengle South Road, Huangpu Street, Huangpu District, Guangzhou

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guang Dong

City:

Guang Zhou

单位(医院):

广州市黄埔区黄埔街社区卫生服务中心

具体地址:

广州市黄埔区丰乐南路88号大院23#首层

Institution
hospital:

Huangpu Street Community Health Service Center, Huangpu District, Guangzhou

Address:

The first floor of the 23# compound at No. 88 Fengle South Road, Huangpu Street, Huangpu District, Guangzhou

经费或物资来源:

广州市卫生健康科技项目

Source(s) of funding:

Guangzhou Health Science and Technology Project

研究疾病:

骨转移癌痛

研究疾病代码:

Target disease:

Bone metastatic cancer pain

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

这项研究目的是对医联体电针耳穴结合三阶梯止痛药物对肾虚血瘀骨转移癌针灸镇痛干预研究,制定可推广的、实用性强的医者干预和癌痛患者自我管理的针灸镇痛方案。这项研究已通过广州市黄埔区黄埔街社区卫生服务中心伦理委员会的审查。

Objectives of Study:

The purpose of this study is to study the acupuncture analgesic intervention of the medical association electro-acupuncture ear acupuncture combined with three-step analgesic drugs for kidney deficiency blood and stasis metastatic carcinoma, and to formulate a generalizable and practical doctor intervention and self-management acupuncture analgesia program for cancer patients. The study has been reviewed by the Ethics Committee of the Huangpu Street Community Health Service Center in Huangpu District, Guangzhou.

药物成份或治疗方案详述:

(1)治疗组措施:电针耳穴结合止痛药物 针刺治疗:主穴:大椎,华佗夹脊,命门,肾俞,四花穴 操作方法:上述穴位常规消毒后进针,徐入徐出的提插手法,得气后留针30分钟,夹电,连续波。 耳穴:取肝,脾,皮质,内分泌,神门 止痛药物疗法 上述治疗同时进行,每周2次治疗,连续4周。 (2)对照组措施:药物止痛疗法 按照原医嘱口服或者外用止痛药物。

Description for medicine or protocol of treatment in detail:

(1) Treatment group measures: electric needle ear acupuncture combined with analgesic drugs Acupuncture treatment: main acupuncture: large vertebrae, Hua Tuo ridge, life gate, kidney Yu, four flower acupuncture Operation method: the needle is entered after the routine disinfection of the above acupuncture points, the needle is lifted in and out, the needle is left for 30 minutes after getting the gas, and the electricity is clamped and the continuous wave is continuous. Ear acupuncture: take the liver, spleen, cortex, endocrine, shenmen Analgesic drug therapy The above treatment is carried out simultaneously, 2 times a week for 4 weeks. (2) Control group measures: drug analgesic therapy Oral or topical pain medication as prescribed by the original doctor.

纳入标准:

经组织学或细胞学确诊为恶性肿瘤且经X线片、CT、MRI、ECT 或PET-CT 检査结合临床表现证实为骨转移癌。证型符合肾虚血瘀型患者。①年龄30 ~75岁,预计生存期大于1个月;②根据2015年美国成人癌痛临床实践指南,癌痛病因,直接由肿瘤引起,包括原发肿瘤和/或转移性肿瘤引起的疼痛;由肿瘤治疗引起的疼痛;与肿瘤相关的疼痛;③有与肿瘤骨转移相关的骨骼疼痛且癌痛NRS (疼痛数字评定法)>4分;④卡氏功能状态评分(KamofskyPerformance Status,KPS)≥60分;⑤语言表达能力正常,对自身一般状况和疼痛有判断能力,依从性良好,与合作研究者且能表达评价疼痛。

Inclusion criteria

Histological or cytologically confirmed malignancy and clinical manifestations by X-ray, CT, MRI, ECT, or PET-CT tests combined with bone metastatic carcinoma. The syndrome is consistent with patients with renal deficiency and blood stasis. (1) Age 30 to 75 years old, estimated survival period greater than 1 month; (2) According to the 2015 U.S. Clinical Practice Guidelines for Cancer Pain in Adults, the cause of cancer pain is directly caused by tumors, including pain caused by primary tumors and/or metastatic tumors; pain caused by tumor treatment; pain associated with tumors; (3) bone pain associated with bone metastases of tumors and cancer pain NRS (Pain Numerical Assessment Method) > 4 points; (4) Kamofsky Performance Status (KPS) ≥ 60 points; (5) Normal language expression ability, judgment ability of their general condition and pain, good compliance, and can express and evaluate pain with cooperative researchers.

排除标准:

①治疗前疼痛剧烈,NRS≥9分,吗啡用量较大仍不能缓解疼痛者;②一个月内对肿瘤部位或疼痛部位使用了放疗、化疗或神经阻断治疗;③非癌性疼痛,如手术切口痛等;④合并严重心、肝、肾、造血系统功能不全等;⑤晕针或对针灸治疗存在恐惧或抗拒者;⑥有智力障碍或伴有听力、精神、认知、意识障碍者;⑦参与其他研究项目者。

Exclusion criteria:

(1) Severe pain before treatment, NRS ≥ 9 points, morphine dosage is large but still can not relieve pain; (2) within one month of the tumor site or pain site used radiotherapy, chemotherapy or nerve blockade therapy; (3) non-cancer pain, such as surgical incision pain, etc.; (4) combined severe heart, liver, kidney, hematopoietic system insufficiency, etc.; (5) halo needles or fear or resistance to acupuncture treatment; (6) intellectual disabilities or accompanied by hearing, mental, cognitive, and cognitive impairment; (7) participants in other research projects.

研究实施时间:

Study execute time:

From 2020-05-01

To      2021-12-21

征募观察对象时间:

Recruiting time:

From 2020-05-01

To      2021-12-21

干预措施:

Interventions:

组别:

对照组

样本量:

30

Group:

control

Sample size:

干预措施:

药物

干预措施代码:

2

Intervention:

drug

Intervention code:

组别:

治疗组

样本量:

30

Group:

treatment

Sample size:

干预措施:

电针耳穴

干预措施代码:

1

Intervention:

Electro-needle ear acupuncture

Intervention code:

样本总量 Total sample size : 30

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guang Dong

City:

Guang Zhou

单位(医院):

广州市黄埔区黄埔街社区卫生服务中心

单位级别:

一级

Institution/hospital:

Huangpu Street Community Health Service Center, Huangpu District, Guangzhou

Level of the institution:

one

测量指标:

Outcomes:

指标中文名:

疼痛评分NRS

指标类型:

主要指标

Outcome:

NRS

Type:

Primary indicator

测量时间点:

干预2,7,14,28天

测量方法:

NRS

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

β-EP

组织:

Sample Name:

β-EP

Tissue:

blood

人体标本去向

使用后销毁

说明

0.5年

Fate of sample 

Destruction after use

Note:

0.5year

征募研究对象情况:

结束

Completed

年龄范围:

最小 30
Min age years
最大 75
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

电脑数字随机

Randomization Procedure (please state who generates the random number sequence and by what method):

Computer number random allocation method

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

OSID 2021.12.30

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

OSID 2021.12.30

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集和管理,一医生输写保存病例记录表(Case Record Form, CRF),二为同时通过电子采集和管理系统(Electronic Data Capture, EDC)采集临床数据,如ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and management, one doctor writes and saves the case record form (CRF), and the other is to collect clinical data through electronic data capture (EDC) at the same time, such as ResMan

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above